Seeking men and women with cancer (breast, head and neck, squamous cell carcinoma, lymphoma, pancreatic, liver, colon, lung, bile duct, chordoma of sacrum, or sarcoma) that has not responded to chemotherapy (refractory) for a study of an investigational drug.
Participants in this study will get either the investigational drug alone or the investigational drug and one of two different immunotherapy drugs.
What we're hoping for
We are studying whether an investigational drug for cancers that have not responded to chemotherapy improves delivery of chemotherapy to the tumor or cancer cells and reduces or controls the cancer.
ClinicalTrials.gov Identifier: NCT03058289